Retracted: Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer

Detalles Bibliográficos
Autor principal: International, BioMed Research
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307199/
https://www.ncbi.nlm.nih.gov/pubmed/37388379
http://dx.doi.org/10.1155/2023/9870382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307199/
https://www.ncbi.nlm.nih.gov/pubmed/37388379
http://dx.doi.org/10.1155/2023/9870382

Ejemplares similares